Company Lookup
عربي
 
 

Market News

This Month News

This Month News

send to a friend by email

PHARMACARE records net income of $3.41 million at the end of 2016

2017-02-19

According to the parent company data of Dar Al-Shifa Pharmaceuticals Company PHARMACARE for the year-end 2016, net profit after tax reached 3,414,672 USD, compared with a net profit after tax of 1,849,164 USD in the audited data for 2015, a net increase of 84.7%. Total assets of the company reached 51,137,343 USD as of December 31st, 2016, compared to total assets of 45,615,682 USD as of December 31st, 2015, a net increase of 12.1%. Total liabilities of the company reached 23,792,491 USD as of December 31st, 2016, compared to total liabilities of 21,072,784 USD as of December 31st, 2015, a net increase of 12.9%. Net ownership equity of the company reached 27,344,853 USD as of December 31st, 2016, compared with a net ownership equity of 24,542,898 USD as of December 31st, 2015, a net increase of 11.4%.


 

2024-04-18
Al-Quds Index increases amid growing in the dividends proposals momentum for 2023

2024-04-15
TPIC proposes distributing 5% stocks dividends for the year 2023

2024-04-14
PIBC recommends distributing 2.5641% stocks dividends for the year 2023

2024-04-14
ABRAJ recommends converting the company from public shareholding to private shareholding

2024-04-14
NCI recommends distributing 12% cash dividends for the year 2023

2024-04-04
TRUST approves distributing 10% cash dividends for the year 2023

2024-04-04
Al-Quds Index stands-still with the start of April

2024-04-03
TIC approves distributing 15% cash dividends for the year 2023

2024-04-01
NSC recommends distributing 7% stocks dividends for the year 2023

 

 

 
Sahem Trading & Investments Company - PEX Member and licensed by PCMA
© All Rights Reserved 2013
PHP Notice: Undefined index: archive in C:\Inetpub\wwwroot\sahem\menu.php on line 403